Paul N. Schofield

Paul N. Schofield

Auto-generated profile, based on publicly available information

Paul N. Schofield

Department of Physiology, Development and Neuroscience, University of Cambridge

Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2014 in Genome Biology
Verified
Journal Article
Open access
PDF file
JIJonas Ibn-Salem
Jonas Ibn-Salem
SKSebastian Köhler
Sebastian Köhler
MLMichael I Love
Michael I Love
HCHo-Ryun Chung
Ho-Ryun Chung
NHNi Huang
Ni Huang
PRPeter N. Robinson
Peter N. Robinson
Background: Recent data from genome-wide chromosome conformation capture analysis indicate that the human genome is divided into conserved megabase-sized self-interacting regions called topological domains. These topological domains form the regulatory backbone of the genome and are separated by regulatory boundary elements or barriers. Copy-number variations can potentially alter the topological domain architecture by deleting or duplicating the barriers and thereby allowing enhancers from neighboring domains to ectopically activate genes causing misexpression and disease, a mutational mechanism that has recently been termed enhancer adoption. Results: We use the Human Phenotype Ontology database to relate the phenotypes of 922 deletion cases recorded in the DECIPHER database to monogenic diseases associated with genes in or adjacent to the deletions. We identify combinations of tissue-specific enhancers and genes adjacent to the deletion and associated with phenotypes in the corresponding tissue, whereby the phenotype matched that observed in the deletion. We compare this computationally with a gene-dosage pathomechanism that attempts to explain the deletion phenotype based on haploinsufficiency of genes located within the deletions. Up to 11.8% of the deletions could be best explained by enhancer adoption or a combination of enhancer adoption and gene-dosage effects. Conclusions: Our results suggest that enhancer adoption caused by deletions of regulatory boundaries may contribute to a substantial minority of copy-number variation phenotypes and should thus be taken into account in their medical interpretation.

15 June 2022 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
JJJulius Jacobsen
Julius Jacobsen
MBMichael Baudis
Michael Baudis
GBGareth Baynam
Gareth Baynam
JBJacques S. Beckmann
Jacques S. Beckmann
SBSergi Beltran
Sergi Beltran
PRPeter N. Robinson
Peter N. Robinson

6 April 2017 in Briefings in Bioinformatics
Verified
Journal Article
Open access
PDF file
Georgios V. GkoutosGeorgios V. Gkoutos
Georgios V. Gkoutos
PSPaul N Schofield
Paul N Schofield
RHRobert Hoehndorf
Robert Hoehndorf
The past decade has seen an explosion in the collection of genotype data in domains as diverse as medicine, ecology, livestock and plant breeding. Along with this comes the challenge of dealing with the related phenotype data, which is not only large but also highly multidimensional. Computational analysis of phenotypes has therefore become critical for our ability to understand the biological meaning of genomic data in the biological sciences. At the heart of computational phenotype analysis are the phenotype ontologies. A large number of these ontologies have been developed across many domains, and we are now at a point where the knowledge captured in the structure of these ontologies can be used for the integration and analysis of large interrelated data sets. The Phenotype And Trait Ontology framework provides a method for formal definitions of phenotypes and associated data sets and has proved to be key to our ability to develop methods for the integration and analysis of phenotype data. Here, we describe the development and products of the ontological approach to phenotype capture, the formal content of phenotype ontologies and how their content can be used computationally.

1 October 1985 in Nature
Verified
Journal Article
Closed access
IJIan J. Jackson
Ian J. Jackson
PSPaul Schofield
Paul Schofield
BHBrigid Hogan
Brigid Hogan

28 January 2015 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
RHRobert Hoehndorf
Robert Hoehndorf
LSLuke Slater
Luke Slater
PSPaul N Schofield
Paul N Schofield
Georgios V. GkoutosGeorgios V. Gkoutos
Georgios V. Gkoutos
Background: Many ontologies have been developed in biology and these ontologies increasingly contain large volumes of formalized knowledge commonly expressed in the Web Ontology Language (OWL). Computational access to the knowledge contained within these ontologies relies on the use of automated reasoning. Results: We have developed the Aber-OWL infrastructure that provides reasoning services for bio-ontologies. Aber-OWL consists of an ontology repository, a set of web services and web interfaces that enable ontology-based semantic access to biological data and literature. Aber-OWL is freely available at http://aber-owl.net . Conclusions: Aber-OWL provides a framework for automatically accessing information that is annotated with ontologies or contains terms used to label classes in ontologies. When using Aber-OWL, access to ontologies and data annotated with them is not merely based on class names or identifiers but rather on the knowledge the ontologies contain and the inferences that can be drawn from it.

6 February 2019 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
IBImane Boudellioua
Imane Boudellioua
MKMaxat Kulmanov
Maxat Kulmanov
PSPaul N. Schofield
Paul N. Schofield
Georgios V. GkoutosGeorgios V. Gkoutos
Georgios V. Gkoutos
RHRobert Hoehndorf
Robert Hoehndorf
Prioritization of variants in personal genomic data is a major challenge. Recently, computational methods that rely on comparing phenotype similarity have shown to be useful to identify causative variants. In these methods, pathogenicity prediction is combined with a semantic similarity measure to prioritize not only variants that are likely to be dysfunctional but those that are likely involved in the pathogenesis of a patient’s phenotype. We have developed DeepPVP, a variant prioritization method that combined automated inference with deep neural networks to identify the likely causative variants in whole exome or whole genome sequence data. We demonstrate that DeepPVP performs significantly better than existing methods, including phenotype-based methods that use similar features. DeepPVP is freely available at https://github.com/bio-ontology-research-group/phenomenet-vp . DeepPVP further improves on existing variant prioritization methods both in terms of speed as well as accuracy.